Explorna Therapeutics
KRSCompany age:
Age:
6 y. 7 m. 25 d.
Share capital:
Share capital:
5 000 PLN
Company Explorna Therapeutics
KRS
0000786638
NIP
7010925631
REGON
38337731100000
| Address | UL. ŻWIRKI I WIGURY 93-2157, PL-02-089, WARSZAWA | |
| Voivodeship | Masovian | |
| Email address |
|
|
| Website | explorna.com |
Add to phone
Scan the QR code to add the company’s contact details directly to your phone.
Management
Jemielity Jacek, prezes zarządu
Other management members ›
Beneficiaries of
2 beneficiaries
More ›
| Rating | |||
| Main industry | Research and experimental development on biotechnology | ||
| Account number |
PL29 1090 2590 0000 0001 5153 7725
PL92 1090 2590 0000 0001 5153 7852
PL28 1090 2590 0000 0001 5153 7743
PL59 1090 2590 0000 0001 5153 7767 PL08 1140 2004 0000 3202 7985 0650 PL42 1140 2004 0000 3202 7985 1008 PL42 1140 2004 0000 3412 1104 4023 PL61 1140 2004 0000 3902 8025 8693 PL06 1090 2590 0000 0001 5196 1835 PL48 1140 2004 0000 3212 1242 8688 PL87 1140 2004 0000 3502 7989 1470 |
| Patents | 0 active patents More › |
PKD codes:
72.11.Z - Research and experimental development on biotechnology
20.59.Z - Manufacture of other chemical products n.e.c.
21.10.Z - Manufacture of basic pharmaceutical products
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
84.12.Z - Regulation of health care, education, cultural services and other social services
85.60.Z - Educational support activities
86.90.E - Other human health activities not elsewhere classified
EXPLORNA THERAPEUTICS was established on 2019-05-16 and is currently located at UL. ŻWIRKI I WIGURY 93-2157, PL-02-089, WARSZAWA. The main activity of the company is scientific research and development. Other activities carried out by the company include research and experimental development on biotechnology, manufacture of other chemical products n.e.c., manufacture of basic pharmaceutical products, other research and experimental development on natural sciences and engineering, other professional, scientific and technical activities not elsewhere classified and others. As per the latest entry in the National Court Register, the current management board of the company comprises 5 individual(s). The most recent update in the National Court Register was recorded on 2025-06-27.